EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of impaired kidney function on outcomes and treatment effects of oral anticoagulant regimes in patients with atrial fibrillation in a real-world registry

Christian Salbach iD, Barbara Ruth Milles iD, Hauke Hund, Moritz Biener iD, Matthias Mueller-Hennessen, Norbert Frey, Hugo Katus, Evangelos Giannitsis, Mustafa Yildirim

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0310838 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Christian Salbach und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Atrial Fibrillation, Registries, Anticoagulants, Stroke. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer, Daiichi Sankyo Europe.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The impact of impaired kidney function on outcomes and treatment benefits of vitamin-K antagonists (VKA) versus direct oral anticoagulants (DOAC) in patients with atrial fibrillation (AF) has insufficiently been investigated in randomized controlled studies (RCTs). Most studies and registries are either biased due to incomplete enrolment of consecutive patients in large pharma industry sponsored registries, or due to short recruitment periods or incomplete assessment of important variables in national registries.

Methods

This study uses data from the Heidelberg Registry of Atrial Fibrillation (HERA-FIB), a retrospective single-center registry of 10,222 consecutive patients with AF presenting to the emergency department of University Hospital of Heidelberg from June 2009 until March 2020. Rates of all-cause mortality, stroke, major bleeding and myocardial infarction (MI) were related to the presence and severity of impaired presenting kidney function, as well as to assigned treatment with VKA vs. DOAC.

Results

The risks for all-cause mortality (HR: 3.26, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationRegistriesAnticoagulantsStrokeHemorrhageHumansMaleFemaleAgedRetrospective StudiesAdministration, OralAged, 80 and overTreatment OutcomeMiddle AgedMyocardial InfarctionVitamin KGlomerular Filtration RateKidney

Substanzen

AnticoagulantsVitamin K

Autor:innen und Institutionen

  • Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany.

ORCID-Profile: Christian Salbach, Barbara Ruth Milles, Moritz Biener

Förderung

  • Bayer
  • Daiichi Sankyo Europe

Zitieren

APA

Salbach, C., Milles, B. R., Hund, H., Biener, M., Mueller-Hennessen, M., Frey, N., Katus, H., Giannitsis, E., & Yildirim, M. (2024). Effect of impaired kidney function on outcomes and treatment effects of oral anticoagulant regimes in patients with atrial fibrillation in a real-world registry. PLOS ONE. https://doi.org/10.1371/journal.pone.0310838

Vancouver

Salbach C, Milles BR, Hund H, Biener M, Mueller-Hennessen M, Frey N, et al. Effect of impaired kidney function on outcomes and treatment effects of oral anticoagulant regimes in patients with atrial fibrillation in a real-world registry. PLOS ONE. 2024. doi:10.1371/journal.pone.0310838

BibTeX
@article{Salbach2024,
  author = {Salbach, Christian and Milles, Barbara Ruth and Hund, Hauke and Biener, Moritz and Mueller-Hennessen, Matthias and Frey, Norbert and Katus, Hugo and Giannitsis, Evangelos and Yildirim, Mustafa},
  title = {Effect of impaired kidney function on outcomes and treatment effects of oral anticoagulant regimes in patients with atrial fibrillation in a real-world registry},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0310838}
}
Kostenlos starten →